Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( August )
Competency-based interviewing: Selling your skillset
Drawing on your previous triumphs and failures can help you prove you're up to the job. But preparation is the key to success.(more)
Welcome to the real world
Matthew Gordon examines the differences between observational studies and phase III clinical trials(more)
Drug regulation: still room for improvement
The Medicines Act is 40 years old this year, but regulations and regulators have to change to keep up with rapid changes in medicines and society, says Les Rose.(more)
PharmafocusNews Register for New Alert
News for October 2004
Previous Months: July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Payments by Results blamed for foundation trust trouble
Regulator steps in ..(more)

 Cipralex shows fewer side-effects than Efexor
US and European studies conducted..(more)

 Stroke breakthrough buoys UK stem cell company
Major breakthrough for ReNeuron..(more)

 Buoyant Roche to enter cholesterol market
Japanese alliance announced..(more)

 Equality champion to tackle NHS diversity agenda
NHS workforce to reflect community..(more)

 Non-patronising medicine guides launched
Guides launched for Ask About Medicines Week..(more)

 Abbott third quarter profits grow as Humira sales soar
Growth threatened by generics..(more)

 International cancer research initiative launched
Research fellowships to be funded..(more)

 Sid escapes from salt manufacturers' attack
ASA rejects complaints..(more)

 RSA launches consultancy division
New opportunity for clients..(more)

 In-depth medicines guides for patients launched
Patients want to take more active role..(more)

 Diabetes drug another setback for AstraZeneca
New drug delayed by a year..(more)

 Immunisation factfile launched to promote 5-in-1 jab
Government promotes new vaccine..(more)

 Pfizer distances Celebrex from COX-II safety concerns
Pfizer responds to Vioxx withdrawal..(more)

 GP commissioning returns but PCTs will hold purse strings
Patient-centred care the target..(more)

 NHS spending on diabetes to double
Better prevention and treatment needed..(more)

 Chiron suspension threatens US flu jab shortage
MHRA imposes suspension..(more)

 Wyeth and Roche share top drug innovation award
Panel impressed with both drugs..(more)

 Advert wakes GPs up to the problem of restless legs
GSK prepares drug filing..(more)

 Reid promises 'hundreds of millions' in PPRS savings
UK industry price cuts look certain..(more)

 Markets stunned as Merck withdraws blockbuster Vioxx
Decision based on trial results..(more)

 It's war (and healthcare costs) between Bush and Kerry
Election battle intensifies..(more)

 Novartis launches kidney drug to rival CellCept
Myfortic launched in UK..(more)

 Pfizer to buy UK-based drug delivery specialists
Pfizer builds respiratory presence..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.